SPACE-Peptide succesfully improves dermis penetration of amniotic membrane stem cell metabolite product as antiaging
DOI:
https://doi.org/10.35814/jifi.v24i2.2048Keywords:
AMSCMP, irritation, penetration, SPACE-PeptideAbstract
Amniotic Membrane Stem Cell Metabolite Product (AMSCMP) is a totipotent stem cell derived metabolite with contains protein size of 75.33 kDa so it is difficult to penetrate the dermis. Skin Penetrating and Cell Entering (SPACE) proven to facilitate protein molecule penetration. The advantage of SPACE its reversible and non irritating. This study was to assess the parameters of successful penetration and the level of skin irritation after AMSCMP was added with SPACE Peptide. The method used is in vivo research using test animals, then penetration analysis is seen from measuring the depth of staining, while the penetration test looks at the changes that occur in the skin after the sample is applied in the form of edema, PMN and degenerative. Penetration tests showed differences in color fluorescence before and after the addition of SPACE peptide. This indicates that the parts of the mouse skin that exhibited color fluorescence had better penetration (F2, F3, F4) compared to those that did not fluoresce (F1). The F1 measurement results did not have a penetration value, while F2, F3, and F4 had values of more than 1200 micrometers. The irritation test showed that F1 and F2 had no irritation index (zero) with edema, polymorphonuclear, and degenerative parameters, while F3 and F4 had a value of 1.3 from the average results with a very mild irritation category. The study results demonstrated that the addition of SPACE significantly increased the penetration of the formulation. Based on statistical analysis using SPSS, the penetration parameter differed significantly among the formulas (p<0.05), indicating that the addition of SPACE had a significant effect on enhancing the penetration of the active ingredient. In contrast, the irritation test results showed that the addition of SPACE caused irritation in the very mild category. Nevertheless, statistical analysis revealed no significant difference in irritation scores among the formulas (p > 0.05), suggesting that the addition of SPACE did not significantly affect the degree of irritation caused.
References
[1] J. Varani et al., “Decreased Collagen Production in Chronologically Aged Skin Roles of Age-Dependent Alteration in Fibroblast Function and,” Am. J. Pathol., vol. 168, no. 6, pp. 1861–1868, 2006, doi: 10.2353/ajpath.2006.051302.
[2] D. I. K. Sari, T. Erawati, A. Miatmoko, C. R. S. Prakoeswa, and W. Soeratri, “Characterization and Stability Study of Amniotic Membrane Stem Cell Metabolite Product (AMSC-MP),” International Journal of Pharma Research and Health Sciences, vol. 8, no. 1, pp. 3126–3130, Feb. 2020, doi: 10.21276/ijprhs.2020.01.02.
[3] R. Islam, Md. Shaifur Ra, S. M. Asaduzzama, and M. Shahedur R, “Properties and Therapeutic Potential of Human Amniotic Membrane,” Asian Journal of Dermatology, vol. 7, no. 1, pp. 1–12, 2015, doi: 10.3923/ajd.2015.1.12.
[4] A. P. Hinck et al., “Transforming growth factor β1: Three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor β2,” Biochemistry, vol. 35, no. 26, pp. 8517–8534, 1996, doi: 10.1021/bi9604946.
[5] M. B. Sporn, A. B. Roberts, L. M. Wakefield, and R. K. Assoian, “Transforming growth factor-β: Biological function and chemical structure,” Science (1979)., vol. 233, no. 4763, pp. 532–534, 1986, doi: 10.1126/science.3487831.
[6] M. El-domyati, T. S. El-ammawi, W. Medhat, G. Mahoney, J. Uitto, and O. Moawad, “Expression of transforming growth factor- b after different non-invasive facial rejuvenation modalities,” 2014.
[7] S. Brito, M. Baek, and B. H. Bin, “Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery,” Nov. 01, 2024, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/pharmaceutics16111403.
[8] S. Kumar, M. Chen, A. C. Anselmo, J. A. Muraski, and S. Mitragotri, “Enhanced epidermal localization of topically applied steroids using SPACETM peptide,” Drug Deliv. Transl. Res., vol. 5, no. 5, pp. 523–530, 2015, doi: 10.1007/s13346-015-0232-4.
[9] S. Menegatti, M. Zakrewsky, S. Kumar, J. S. De Oliveira, J. A. Muraski, and S. Mitragotri, “De Novo Design of Skin-Penetrating Peptides for Enhanced Transdermal Delivery of Peptide Drugs,” Adv. Healthc. Mater., vol. 5, no. 5, pp. 602–609, 2016, doi: 10.1002/adhm.201500634.
[10] S. Cells, S. Malerich, and D. Berson, “Next Generation Cosmeceuticals The Latest in Peptides , Growth Factors , Cosmeceuticals Stem cells Growth factors Peptides Photoaging Rhytides Cytokines,” Dermatol. Clin., vol. 32, no. 1, pp. 13–21, 2014, doi: 10.1016/j.det.2013.09.003.
[11] O. Kose, P. Erkekoglu, S. Sabuncuoglu, and B. Kocer-Gumusel, “Evaluation of skin irritation potentials of different cosmetic products in Turkish market by reconstructed human epidermis model,” Regulatory Toxicology and Pharmacology, vol. 98, pp. 268–273, Oct. 2018, doi: 10.1016/j.yrtph.2018.08.010.
[12] R. Rahmadewi et al., “The Efficacy of Amniotic Membrane Stem Cell (AMSC) Metabolite Product and Vitamin e for Wrinkles, Spots, and Pores in Photoaging,” Dermatol. Res. Pract., vol. 2020, 2020, doi: 10.1155/2020/1584541.
[13] P. Desai, R. A. M. R. Patlolla, and M. Singh, “Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery,” vol. 27, no. October, pp. 247–259, 2010, doi: 10.3109/09687688.2010.522203.
[14] P. A. Wender et al., “Oligocarbamate Molecular Transporters : Design , Synthesis , and Biological Evaluation of a New Class of Transporters for Drug Delivery,” pp. 13382–13383, 2002.
[15] S. H. Lim, Y. Sun, T. Madanagopal Thiruvallur, V. Rosa, and L. Kang, “Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification,” Sci. Rep., vol. 8, no. 1, Dec. 2018, doi: 10.1038/s41598-017-18454-z.
[16] A. M. Muhammad et al., “Skin-penetrating peptides (SKPs): Enhancing skin permeation for transdermal delivery of pharmaceuticals and cosmetic compounds,” Mar. 15, 2025, Elsevier B.V. doi: 10.1016/j.ijpharm.2025.125339.
[17] Y. Wang, M. Wang, S. Xiao, P. Pan, P. Li, and J. Huo, “The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in chinese subjects: A randomized, placebo-controlled study,” Am. J. Clin. Dermatol., vol. 14, no. 2, pp. 147–153, Apr. 2013, doi: 10.1007/s40257-013-0009-9.
[18] K. Saar et al., “Cell-penetrating peptides: A comparative membrane toxicity study,” Anal. Biochem., vol. 345, no. 1, pp. 55–65, 2005, doi: 10.1016/j.ab.2005.07.033.
[19] S. El-andaloussi, P. J. Arver, and H. J. Johansson, “Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides : a comparative study,” vol. 292, pp. 285–292, 2007, doi: 10.1042/BJ20070507.
[20] S. El-Andaloussi, T. Holm, and U. Langel, “Cell-Penetrating Peptides: Mechanisms and Applications,” Curr. Pharm. Des., vol. 11, no. 28, pp. 3597–3611, 2005, doi: 10.2174/138161205774580796.
[21] W. Huang, J. Ran, Y. Du, and C. Cao, “New Insights into the Anti-Aging Mechanism of Collagen Peptides—Emphasis on Lysosomes and Mitochondria Function,” Mar. 01, 2026, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/molecules31050763.
[22] B. He, F. Wang, and L. Qu, “Role of peptide–cell surface interactions in cosmetic peptide application,” Front. Pharmacol., vol. 14, 2023, doi: 10.3389/fphar.2023.1267765.
[23] L. B. Lopes, “Overcoming the cutaneous barrier with microemulsions,” Feb. 28, 2014, MDPI AG. doi: 10.3390/pharmaceutics6010052.
[24] A. Seweryn, “Interactions between surfactants and the skin – Theory and practice,” Jun. 01, 2018, Elsevier B.V. doi: 10.1016/j.cis.2018.04.002.
[25] E. O. Bakhrushina et al., “Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation,” Jul. 01, 2025, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/pharmaceutics17070936.
[26] O. / Ocde, “Section 4 Health effects OECD GUIDELINES FOR THE TESTING OF CHEMICALS In Vitro Skin Irritation: Reconstructed Human Epidermis Test Methods INTRODUCTION,” 2025. [Online]. Available: http://www.oecd.org/termsandconditions/
[27] T. Fu et al., “Cell Penetrating Peptide as a High Safety Anti-Inflammation Ingredient for Cosmetic Applications”.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 JURNAL ILMU KEFARMASIAN INDONESIA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.












